Clinical Significance of an R1 Resection for Pancreatic Ductal Adenocarcinomas Treated by Intensive FOLFIRINOX Induction-Based Chemotherapy and Extended Pancreatectomies.

Date publication

décembre 2025

Journal

Annals of surgical oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr AVEROUS Gerlinde , Pr BACHELLIER Philippe

Tous les auteurs :
Addeo P, Paul C, Averous G, Furda PP, Marchitelli I, Bachellier P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41329313

Résumé

This study assessed the prognostic significance of an R1 resection after intensive FOLFIRINOX (FX) neoadjuvant chemotherapy in patients with borderline (BL) and locally advanced pancreatic ductal adenocarcinomas.

Mots clés

Arterial resection, FOLFIRINOX, Pancreatic adenocarcinoma, R1 resection, Venous resection

Référence

Ann Surg Oncol. 2025 12 2;: